{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Expanded Access Protocol (EAP) for Patients Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release.","item":"https:\/\/www.regionalcancercare.org\/trials\/expanded-access-protocol-eap-for-patients-receiving-lisocabtagene-maraleucel-that-is-nonconforming-for-commercial-release\/#breadcrumbitem"}]}